Research study Program year 2023 Source: CMS Open Payments

Phase I Abemaciclib & BI 836845

Research payments

$1,100,079

24 payments

Through program year 2023, $1,100,079 in research payments was reported against Phase I Abemaciclib & BI 836845, across 24 payments.

Paid by (largest first): Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim Pharma GmbH & Co.KG
ClinicalTrials.gov: No trial number was reported for this study

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$183,644	5
2022	Research	$369,292	4
2021	Research	$218,054	7
2020	Research	$117,177	3
2019	Research	$211,913	5

Breakdown

Who paid Research payments · program years 2019–2023

Boehringer Ingelheim Pharmaceuticals, Inc. $752,800 22 payments
Boehringer Ingelheim Pharma GmbH & Co.KG $347,279 2 payments

Who received the money Research payments · program years 2019–2023

The University Of North Carolina Organisation paid for research $299,283 5 payments
The University Of North Carolina At Chapel Hill Organisation paid for research $270,106 1 payment
University Of California Los Angeles Organisation paid for research $146,570 2 payments
Allison Curtis Kingsley Meoz Michael Organisation paid for research $130,783 4 payments
UNC Neurology MS Center Organisation paid for research $77,173 1 payment
Resnick Neuropsychiatric Hospital At Teaching hospital · CA $38,327 2 payments
Regents Of The Univ Of Minnes Organisation paid for research $37,747 1 payment
Yale University School Of Medicine Organisation paid for research $36,790 2 payments
Regents of the University of Mn Organisation paid for research $32,760 4 payments
Yale School Of Medicine Organisation paid for research $23,915 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

6 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.